Clinical Trial Update: Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selenium replacement in patients with severe sepsis and septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: Gil Joon Suh | Conditions: Sepsis, Shock, Septic | Phase 2 | Status: WITHDRAWN